Keyword: Edmond de Rothschild Investment Partners
The financing equips Crescendo to show whether its vision for dialing up T-cell activity in the tumor microenvironment translates into humans.
The haul makes BioDiscovery 5 the largest fund dedicated to biotechs and medical devices in Europe and tees up De Rothschild to invest in 17 firms.
Genoa Pharmaceuticals has raised $62 million to take its lead candidate into the clinic.
MedLumics has raised $37 million to run clinical trials of its atrial fibrillation device.